Steel sheet coating compositions in which polymeric resin or ceramic properties are produced by admixing an aluminum coordinate complex and an aluminum resin, a polysilazane as a source of silicon, an organic solvent, an organic synthesis catalyst, and optionally a non-metallic, non-ionic, low-nucleophilic base. The admixed coating is applied to sheet steel prior to hot-stamping in order to inhibit surface formation of iron oxides and to improve steel sheet surface characteristics.

The present invention relates in part to nucleic acids encoding proteins, nucleic acids containing non-canonical nucleotides, therapeutics comprising nucleic acids, methods, kits, and devices for inducing cells to express proteins, methods, kits, and devices for transfecting, gene editing, and reprogramming cells, and cells, organisms, and therapeutics produced using these methods, kits, and devices. Methods for inducing cells to express proteins and for reprogramming and gene-editing cells using RNA are disclosed. Methods for producing cells from patient samples, cells produced using these methods, and therapeutics comprising cells produced using these methods are also disclosed.

The present invention relates in part to nucleic acids encoding proteins, nucleic acids containing non-canonical nucleotides, therapeutics comprising nucleic acids, methods, kits, and devices for inducing cells to express proteins, methods, kits, and devices for transfecting, gene editing, and reprogramming cells, and cells, organisms, and therapeutics produced using these methods, kits, and devices. Methods for inducing cells to express proteins and for reprogramming and gene-editing cells using RNA are disclosed. Methods for producing cells from patient samples, cells produced using these methods, and therapeutics comprising cells produced using these methods are also disclosed.

The present invention relates in part to nucleic acids encoding proteins, nucleic acids containing non-canonical nucleotides, therapeutics comprising nucleic acids, methods, kits, and devices for inducing cells to express proteins, methods, kits, and devices for transfecting, gene editing, and reprogramming cells, and cells, organisms, and therapeutics produced using these methods, kits, and devices. Methods for inducing cells to express proteins and for reprogramming and gene-editing cells using RNA are disclosed. Methods for producing cells from patient samples, cells produced using these methods, and therapeutics comprising cells produced using these methods are also disclosed.

A resin composition contains a resin component (A) and a phosphorus-containing flame retardant (B). The resin component (A) contains an epoxy resin (a1), of which the viscosity at 25° C. is equal to or less than 50000 mPa.Math.s. The proportion of the epoxy resin (a1) to the resin component (A) is equal to or greater than 20% by mass. The phosphorus-containing flame retardant (B) includes a phosphorus-containing flame retardant (B1) that neither melts nor thermally decomposes at a temperature lower than 150° C.

A resin composition contains a resin component (A) and a phosphorus-containing flame retardant (B). The resin component (A) contains an epoxy resin (a1), of which the viscosity at 25° C. is equal to or less than 50000 mPa.Math.s. The proportion of the epoxy resin (a1) to the resin component (A) is equal to or greater than 20% by mass. The phosphorus-containing flame retardant (B) includes a phosphorus-containing flame retardant (B1) that neither melts nor thermally decomposes at a temperature lower than 150° C.

A resin composition contains a resin component (A) and a phosphorus-containing flame retardant (B). The resin component (A) contains an epoxy resin (a1), of which the viscosity at 25° C. is equal to or less than 50000 mPa.Math.s. The proportion of the epoxy resin (a1) to the resin component (A) is equal to or greater than 20% by mass. The phosphorus-containing flame retardant (B) includes a phosphorus-containing flame retardant (B1) that neither melts nor thermally decomposes at a temperature lower than 150° C.

A thermoplastic polyester resin composition is obtained by blending, with respect to (A) 100 parts by weight of a thermoplastic polyester resin, (B) 0.1-50 parts by weight of at least one phosphinate selected from phosphinates and diphosphinates, (C) 0.1-10 parts by weight of a phosphazene compound, (D) 0.1-50 parts by weight of a nitrogen-based flame retardant, (E) 0.1-10 parts by weight of a polyfunctional epoxy compound, and (F) 0.1-20 parts by weight of an olefin resin. The ratio of the parts by weight of component (B) and the parts by weight of component (C) is 2.0-8.0.

A thermoplastic polyester resin composition is obtained by blending, with respect to (A) 100 parts by weight of a thermoplastic polyester resin, (B) 0.1-50 parts by weight of at least one phosphinate selected from phosphinates and diphosphinates, (C) 0.1-10 parts by weight of a phosphazene compound, (D) 0.1-50 parts by weight of a nitrogen-based flame retardant, (E) 0.1-10 parts by weight of a polyfunctional epoxy compound, and (F) 0.1-20 parts by weight of an olefin resin. The ratio of the parts by weight of component (B) and the parts by weight of component (C) is 2.0-8.0.

A thermoplastic polyester resin composition is obtained by blending, with respect to (A) 100 parts by weight of a thermoplastic polyester resin, (B) 0.1-50 parts by weight of at least one phosphinate selected from phosphinates and diphosphinates, (C) 0.1-10 parts by weight of a phosphazene compound, (D) 0.1-50 parts by weight of a nitrogen-based flame retardant, (E) 0.1-10 parts by weight of a polyfunctional epoxy compound, and (F) 0.1-20 parts by weight of an olefin resin. The ratio of the parts by weight of component (B) and the parts by weight of component (C) is 2.0-8.0.